MEDTRONIC MINIMED 670G PUMP

Medtronic MiniMed 670G Insulin Pump

The Medtronic MiniMed 670G Insulin Pump is a next-generation insulin pump designed for individuals with type 1 diabetes. This advanced closed-loop system integrates continuous glucose monitoring (CGM) with automated insulin delivery to help users maintain glucose control with minimal intervention. The MiniMed 670G uses the Guardian Sensor 3 to continuously measure glucose levels, automatically adjusting insulin delivery based on real-time data to keep blood glucose levels within a target range. This system is designed to help reduce both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar), offering enhanced control, comfort, and peace of mind.

Key Features:

• Closed-Loop Insulin Delivery System: The MiniMed 670G is the first FDA-approved insulin pump with a hybrid closed-loop system. It automatically adjusts basal insulin delivery every 5 minutes based on real-time glucose readings from the Guardian Sensor 3, helping to keep blood glucose levels within a desired target range with minimal user input.

• SmartGuard™ Technology: With SmartGuard™, the MiniMed 670G system adjusts insulin delivery to help keep glucose levels stable. It continuously learns and adapts to your body’s insulin needs, reducing the burden of manual adjustments and helping you maintain more stable glucose control throughout the day and night.

• Targeted Glucose Range: The MiniMed 670G allows users to set their target glucose range (typically 120-150 mg/dL), with the system working to keep glucose within that range as much as possible, reducing the risk of both highs and lows.

• Auto Mode and Manual Mode: In Auto Mode, the system makes automatic adjustments to basal insulin delivery. In Manual Mode, users can adjust insulin delivery based on their own needs, providing flexibility for active or changing conditions.

• Enhanced Insulin Delivery: The MiniMed 670G delivers insulin through the Medtronic infusion set, which is designed to be discreet, reliable, and comfortable for continuous insulin delivery throughout the day.

• Integration with the Guardian Sensor 3: The MiniMed 670G system pairs with the Guardian Sensor 3 to continuously monitor glucose levels. This CGM technology helps improve accuracy and ensures insulin delivery is adjusted based on real-time glucose measurements.

• Real-Time Glucose Data: With the MiniMed 670G, users can monitor their glucose levels and trends in real-time on the device’s display. The system provides detailed data on glucose levels, insulin delivery, and other important metrics, which can be reviewed through the CareLink™ software for enhanced decision-making.

• Customizable Alerts and Alarms: The system can be set to provide alerts for high or low glucose levels, allowing users to take corrective actions before their glucose levels become problematic. It also provides predictive alerts, warning of potential glucose level changes before they occur.

• Easy-to-Use Interface: The MiniMed 670G features an intuitive, user-friendly interface with a touch screen for easy navigation. Users can easily access and adjust settings, track their glucose trends, and make changes as needed.

How It Works:

1. The Guardian Sensor 3 continuously monitors glucose levels in the interstitial fluid (fluid between cells).

2. The MiniMed 670G insulin pump receives real-time glucose data from the sensor and uses SmartGuard™ technology to adjust basal insulin delivery every 5 minutes.

3. The system works to keep glucose levels within the user’s target range by increasing or decreasing insulin delivery as needed.

4. If a user’s glucose level falls outside the target range, the pump will alert them, prompting corrective action. Users can also switch to Manual Mode for greater control when needed.

5. Data from the pump is available in real-time and can be reviewed using the CareLink™ software, which provides detailed reports to help users and healthcare providers make informed decisions about insulin therapy.

Important Information:

• Sensor Calibration: The MiniMed 670G system requires fingerstick calibration during certain times, particularly when starting the system or if the sensor data is inaccurate. Follow the instructions for proper calibration to ensure accurate glucose readings.

• Pump Compatibility: The MiniMed 670G is designed to be used with the Guardian Sensor 3 and specific Medtronic infusion sets. Ensure that all components are compatible before use.

• Sensor Replacement: The Guardian Sensor 3 is designed to be worn for up to 7 days and should be replaced accordingly to maintain continuous glucose monitoring.

• Storage and Care: Store the MiniMed 670G insulin pump and Guardian Sensor 3 sensor according to the manufacturer’s instructions. Keep devices in a cool, dry place and avoid exposing them to extreme temperatures.

• Water Resistance: The MiniMed 670G insulin pump is water-resistant, but users should follow the guidelines for safe use in water. The Guardian Sensor 3 is also water-resistant, but should not be submerged for extended periods.

Precautions:

• Not for Use with Non-Approved Sensors or Infusion Sets: To ensure proper functionality, use only the Guardian Sensor 3 and Medtronic infusion sets that are specifically designed for use with the MiniMed 670G.

• Skin Sensitivity: Users with sensitive skin should monitor for any irritation or allergic reactions at the infusion or sensor site. If irritation occurs, consult with your healthcare provider for advice.

• Frequent Monitoring: While the MiniMed 670G system automates insulin delivery, users should continue to monitor their glucose levels regularly and follow their healthcare provider’s advice for diabetes management.

Additional Information:

• The MiniMed 670G insulin pump is designed for both adults and children with type 1 diabetes and is a vital part of Medtronic’s integrated diabetes management system. When used in combination with the Guardian Sensor 3 and CareLink™ software, the system provides a comprehensive solution to improve glucose control and quality of life.

The MiniMed 670G insulin pump represents a significant advancement in diabetes care, offering a closed-loop system that adjusts insulin delivery based on continuous glucose data, reducing the frequency of high and low blood glucose levels and providing greater control for individuals with type 1 diabetes.